HeartBeat bio AG
#Cardiac Organoids
#Human 3D Disease Modelling
#High-Throughput Drug Discovery Platform
#Cardiac Drug Discovery
#Heart Failure
#Cardiomyopathy
#Heart Regeneration
#Myocardial Infarction
#Cardiotoxicity
#Cardio-Oncology
Overview
HeartBeat.bio is a VC funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies. Our core technology is based on the world-wide first, self-organizing cardiac organoids (Cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with various cardiac diseases. The Cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.
Contact Details
office@heartbeat.bio
Vienna, Austria
Founded
2021
Employees
10-20
Categories
Keywords
#Cardiac Organoids
#Human 3D Disease Modelling
#High-Throughput Drug Discovery Platform
#Cardiac Drug Discovery
#Heart Failure
#Cardiomyopathy
#Heart Regeneration
#Myocardial Infarction
#Cardiotoxicity
#Cardio-Oncology
Companies teams usually look at after HeartBeat bio AG
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.